Tsunemitsu Senta
Alcon Japan, Ltd.
2
0
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ingerman Avner, MD
Johnson & Johnson
Shared therapeutic areas:
Tuyen Ong, MD
Bausch & Lomb Incorporated
Shared therapeutic areas:
Frédéric de Blay, Pr.
Alyatec
Shared therapeutic areas:
Paul Ratner, MD
Sylvana Research Associates
Shared therapeutic areas:
Worked with same sponsors:
Emma T Villaseñor-Fierro, MD
Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde"
Shared therapeutic areas:
Miriam Becerra-Cotta, MD
Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde"
Shared therapeutic areas:
Laura Trusso
Bausch & Lomb Incorporated
Shared therapeutic areas:
Leopoldo M Baiza-Durán, MD
Clinical Research Department. Laboratorios Sophia SA de CV
Shared therapeutic areas:
Michael Raizman, MD
Ophthalmic Consultants of Boston
Shared therapeutic areas:
Mario Troisi, MD
Azienda Ospedaliera Universitaria OO.RR. S. Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Clinical Evaluation of Opti-Free III (FID 109182) Compared to Opti-Free Plus® in Japan
Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan
All 2 trials loaded